Skip to content

Risk analysis of vaccine preventable diseases in children treated by specialized home palliative care teams

Risk analysis of vaccine preventable diseases in children treated by specialized home palliative care teams - Pallivac

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015045
Enrollment
150
Registered
2018-10-01
Start date
2019-01-02
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B05.8 A37.0

Interventions

Group 1: First experts in pediatric palliative care were asked for their experience with cases of vaccine preventable diseases in palliative treated children. In a second step palliative treated child

Sponsors

UKGM - Universitätsklinikum Giessen und Marburg GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with documentation of vaccines

Exclusion criteria

Exclusion criteria: no documentation of vaccines

Design outcomes

Primary

MeasureTime frame
rate of vaccinations in children treated by shpc (specialized home palliative care) teams

Secondary

MeasureTime frame
case series of children with vaccine preventable disease in Germany treated by shpc teams

Countries

Germany

Contacts

Public ContactHolger Hauch

Deutsches Kinderschmerz- und Palliativzentrum, Vestische Kinderklinik

h.hauch@kinderklinik-datteln.de+ 49 2363 975 719

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026